Head and Neck Squamous Cell Carcinoma (HNSCC) Latest Advances

Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgery.

Journal: medRxiv : the preprint server for health sciences

Published: December 08, 2025

Sentinel lymph node biopsy in T1-T3 N0 oral tongue squamous cell carcinoma.

Journal: Acta oto-laryngologica

Published: December 04, 2025

The importance of specificity of drug treatment in head and neck cancer: current developments in personalized medicine to improve safety and tolerability.

Journal: Expert review of clinical pharmacology

Published: December 04, 2025

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

Journal: JAMA otolaryngology-- head & neck surgery

Published: December 04, 2025

Multi-omics revealed GOT1/ALDH3A1 pathway attenuated head and neck squamous cell carcinoma and increased cisplatin sensitivity through ROS induced by mitochondrial dysfunction.

Journal: Redox report : communications in free radical research

Published: December 02, 2025

Research progress on ICIs therapy for head and neck squamous cell carcinoma

Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery

Published: December 02, 2025

Expression of programmed death-ligand 1 protein in head and neck squamous cell carcinoma and its clinicopathological correlates.

Journal: Biotechnic & histochemistry : official publication of the Biological Stain Commission

Published: December 01, 2025

Research progress on the effect and mechanism of NLRP3 inflammasome in head and neck squamous cell carcinoma

Journal: Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology

Published: November 26, 2025

Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinoma.

Journal: Journal of medicinal chemistry

Published: November 19, 2025

Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma.

Journal: Journal for immunotherapy of cancer

Published: November 15, 2025

Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis.

Journal: Advances in experimental medicine and biology

Published: November 12, 2025

In Silico Analysis of Squamous Cell Carcinoma.

Journal: Advances in experimental medicine and biology

Published: November 12, 2025

Filters

Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgery.

Clinical validation of an HPV whole genome sequencing assay for molecular residual disease detection in HPV-associated head and neck cancer patients treated with surgery.

Sentinel lymph node biopsy in T1-T3 N0 oral tongue squamous cell carcinoma.

Sentinel lymph node biopsy in T1-T3 N0 oral tongue squamous cell carcinoma.

The importance of specificity of drug treatment in head and neck cancer: current developments in personalized medicine to improve safety and tolerability.

The importance of specificity of drug treatment in head and neck cancer: current developments in personalized medicine to improve safety and tolerability.

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

Treatment Interruption and Outcomes in Head and Neck Cancer: A Secondary Analysis of 3 Randomized Clinical Trials.

Multi-omics revealed GOT1/ALDH3A1 pathway attenuated head and neck squamous cell carcinoma and increased cisplatin sensitivity through ROS induced by mitochondrial dysfunction.

Multi-omics revealed GOT1/ALDH3A1 pathway attenuated head and neck squamous cell carcinoma and increased cisplatin sensitivity through ROS induced by mitochondrial dysfunction.

Research progress on ICIs therapy for head and neck squamous cell carcinoma

Research progress on ICIs therapy for head and neck squamous cell carcinoma

Expression of programmed death-ligand 1 protein in head and neck squamous cell carcinoma and its clinicopathological correlates.

Expression of programmed death-ligand 1 protein in head and neck squamous cell carcinoma and its clinicopathological correlates.

Research progress on the effect and mechanism of NLRP3 inflammasome in head and neck squamous cell carcinoma

Research progress on the effect and mechanism of NLRP3 inflammasome in head and neck squamous cell carcinoma

Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinoma.

Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinoma.

Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma.

Arecoline upregulates CD155 expression to facilitate immune evasion in oral squamous cell carcinoma.

Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis.

Characterizing the Head and Neck Cancer Microenvironment: Implications for Immunotherapy and Prognosis.

In Silico Analysis of Squamous Cell Carcinoma.

In Silico Analysis of Squamous Cell Carcinoma.